#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prostate cancer Extraskeletal ossification Carcinoid tumour Bile acid synthesis disorder Hodgkin's disease Hereditary optic atrophy Hypochromic anaemia Rhabdomyosarcoma recurrent Epilepsy with myoclonic-atonic seizures Propionic acidaemia Sexually transmitted disease Renal transplant Systemic mastocytosis Idiopathic pulmonary fibrosis Congenital aplastic anaemia More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Basic Information Crigler-Najjar syndrome – Diagnostics Pituitary-dependent Cushing’s syndrome – Treatment Synovial sarcoma – Treatment Retinitis pigmentosa Factor IX deficiency – Life with Disease Osteosarcoma metastatic – Diagnostics Fragile X syndrome – Life with Disease Turner’s syndrome Alport’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Filgrastim Lamotrigine Protein C Olopatadine Hydrochloride Calcium Oxybate Ads-010 Thiopental Sodium Deferoxamine Mesilate Erythromycin Lactobionate Tislelizumab Timrepigene Emparvovec Skb264 Clomifene Citrate Bi 765845 Marstacimab Degarelix Rbl015.2 Mva-209-Fsp-B3 Topotecan Hydrochloride Emedastine More therapies…

    Learn about Your Condition

    Burkitt's lymphoma Ophthalmoplegia Endometrial cancer stage IV Spinal pain Myofascial pain syndrome Dermatitis atopic Pelvic venous thrombosis Chondrocalcinosis Breast cancer recurrent Thymoma Marfan's syndrome Bipolar disorder Supranuclear palsy Onychomycosis Peripheral spondyloarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Dexmedetomidine on Brain Fluid Flow and Activity in Patients with Neurodegenerative Diseases, Delirium, or Acute Neurological Conditions

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Delirium
    • Nervous system disorder
    • Neurodegenerative disorder
    Investigated Drugs:
    • Dexmedetomidine
    Finland

  • Study on the Safety and Immune Response of GBS-NN/NN2 and Tdap Vaccines in Preventing Group B Strep Infection in Healthy Women Aged 18-49

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Diphtheria Toxoid Adsorbed On Aluminium Hydroxide, Hydrated And Aluminium Phosphate
    • Pertussis Pertactin Adsorbed On Aluminium Hydroxide, Hydrated And Aluminium Phosphate
    • Pertussis Toxoid Adsorbed On Aluminium Hydroxide, Hydrated And Aluminium Phosphate
    Belgium Poland

  • Study on Vitamin D Supplementation (Colecalciferol) and Its Effect on Urinary Calcium Levels in Children and Teens Aged 2 to 18 Years

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Colecalciferol
    France

  • Study on Imaging Beta Cells in Patients with a History of Gestational Diabetes Using Exenatide

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Gestational diabetes
    Investigated Drugs:
    • Exenatide
    The Netherlands

  • Study on the Effect of Xylometazoline Nasal Spray on Physical Capacity in Adults with Chronic Obstructive Pulmonary Disease (COPD)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • XYLOMETAZOLINE HYDROCHLORIDE
    Norway

  • Study on Reducing Eye Prosthesis Discomfort and Discharge Using Retinol Palmitate, Fluorometholone, and Artificial Tears for Patients with Chronic Eye Socket Issues

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Eye inflammation
    Investigated Drugs:
    • Fluorometholone
    • Sodium Hyaluronate
    • Retinol Palmitate
    The Netherlands
Previous Page
1 … 787 788 789 790 791 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!